Sodium Bicarbonate and N-Acetylcysteine tested for the prevention of serious adverse outcomes
3' education - Nov. 14, 2017 - AHA 2017 - Anaheim, CA - Dr Steven Weisbord - Pittsburgh, PA, USAEducational information
This 3-minute education provides a summary of just presented scientific data, recorded during the AHA 2017 congress. The objective is to provide a brief commentary and potential implications of these findings.
Faculty
Dr. Steven Weisbord is a nephrologist at the VA Pittsburgh Healthcare System and Associate Professor of Medicine and Clinical and Translational Science at the Renal-Electrolyte Division at the University of Pittsburgh School of Medicine